Literature DB >> 25230258

Ventilation Distribution Heterogeneity at Rest as a Marker of Exercise Impairment in Mild-to-Advanced COPD.

J Alberto Neder1, Conor D J O'Donnell, Julia Cory, Daniel Langer, Casey E Ciavaglia, Y Ling, Katherine A Webb, Denis E O'Donnell.   

Abstract

The difference between total lung capacity (TLC) by body plethysmography and alveolar volume (VA) from the single-breath lung diffusing capacity measurement provides an index of ventilation distribution inequalities in COPD. The relevance of these abnormalities to dyspnea and exercise intolerance across the continuum of disease severity remains unknown. Two-hundred and seventy-six COPD patients distributed across GOLD grades 1 to 4 and 67 healthy controls were evaluated. The "poorly communicating fraction" (PCF) of the TLC was estimated as the ratio (%) of TLC to VA. Healthy subjects showed significantly lower PCF values compared to GOLD grades 1 to 4 (10 ± 3% vs. 17 ± 8% vs. 27 ± 10% vs. 37 ± 10% vs. 56 ± 11%, respectively; p < 0.05). Pulmonary gas exchange impairment, mechanical ventilatory constraints and ventilation-corrected dyspnea scores worsened across PCF tertiles (p < 0.05). Of note, GOLD grades 1 and 2 patients with the highest PCF values had pronounced exercise ventilatory inefficiency and dyspnea as a limiting symptom. In fact, dyspnea was a significant contributor to exercise limitation only in those with "moderate" or "extensive" PCF (p < 0.05). A receiver operating characteristics curve analysis revealed that PCF was a better predictor of severely reduced maximal exercise capacity than traditional pulmonary function indexes including FEV1 (area under the curve (95% confidence interval) = 0.85 (0.81-0.89), best cutoff = 33.4%; p < 0.01). In conclusion, PCF is a readily available functional marker of gas exchange and mechanical abnormalities relevant to dyspnea and exercise intolerance across the COPD grades.

Entities:  

Keywords:  breathlessness; exertion; lung mechanics; pulmonary function tests

Mesh:

Year:  2014        PMID: 25230258     DOI: 10.3109/15412555.2014.948997

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  6 in total

1.  Cardiorespiratory and sensory responses to exercise in adults with mild cystic fibrosis.

Authors:  Bradley S Quon; Sabrina S Wilkie; Yannick Molgat-Seon; Michele R Schaeffer; Andrew H Ramsook; Pearce G Wilcox; Jordan A Guenette
Journal:  J Appl Physiol (1985)       Date:  2015-10-01

2.  The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity.

Authors:  Surya P Bhatt; Sandeep Bodduluri; Vrishank Raghav; Nirav R Bhakta; Carla G Wilson; Young-Il Kim; Michael Eberlein; Frank C Sciurba; MeiLan K Han; Mark T Dransfield; Arie Nakhmani
Journal:  Ann Am Thorac Soc       Date:  2019-08

3.  Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy.

Authors:  Norihito Omote; Naozumi Hashimoto; Masahiro Morise; Koji Sakamoto; Shinichi Miyazaki; Akira Ando; Yoshio Nakahara; Yoshinori Hasegawa
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-11

4.  Outcomes for symptomatic non-obstructed individuals and individuals with mild (GOLD stage 1) COPD in a population based cohort.

Authors:  Rogelio Perez-Padilla; Fernando C Wehrmeister; Maria Montes de Oca; Maria Victorina Lopez; Jose R Jardim; Adriana Muiño; Gonzalo Valdivia; Ana Maria B Menezes
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-26

5.  Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD.

Authors:  Weigang Dong; Yan Du; Shuping Ma
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-11-21

6.  Transfer coefficient of the lung for carbon monoxide and the accessible alveolar volume: clinically useful if used wisely.

Authors:  J Alberto Neder; Mathieu Marillier; Anne-Catherine Bernard; Denis E O'Donnell
Journal:  Breathe (Sheff)       Date:  2019-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.